MULTIPLI: obtained all regulatory approvals

Afficher
Validation of 48 new preindications relating to access genome sequencing - January 2020
Assises de génétique humaine et médicale de Tours : announcement of new pre-indications for access to genetic diagnosis - January 2020

Practical information on the organisers’ website: http://assises-genetique.org/fr/programme/synoptique.

State decision on the data collector analyser (DCA) organisational model - January 2020

An overall definition of the tool, an analysis of the functional needs of future users and a prefiguration study were carried out.

Validation of 13 pre-indications - December 2019

The organisation of care is being put in place at the beginning of 2020.

Read more

The 13 first-line pre-indications validated by the Operating Committee correspond to clinical indications positively evaluated by the british National Health Service (NHS).

DEFIDIAG: obtained all regulatory approvals - November 2019

DEFIDIAG is a clinical trial in intellectual deficiency. The regulatory approvals of the French National Agency for Medicines and Health Products Safety (ANSM) and the French Data Protection Authority (CNIL) and the favourable opinion of the Institutional Review Board (CPP) have been obtained.

Launch of a new campaign to prioritize pre-indications - November 2019

Dissemination of a questionnaire to the rare diseases and cancer care professionals for the submission of pre-indication projects. It explains: the interest of sequencing the complete genome in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes.

Read more

Dissemination of a questionnaire to the rare diseases and cancer care professionals for the submission of pre-indication projects. It explains: the interest of sequencing the complete genome in the patient care pathway, the technical constraints, the organisation to be set up and the expected volumes.

1st meeting around DEFIDIAG pilot project - November 2019

DEFIDIAG is a clinical trial in intellectual deficiency.

Read more

DEFIDIAG is a clinical trial in intellectual deficiency.

MULTISARC (MULTIPLI): 1st patient enrolled - October 2019

MULTISARC is a clinical trial of the MULTIPLI pilot project in advanced soft-tissue sarcomas.

Industrial sector meetings - September 2019

In all, 108 firms took part, at some point, in all the industrial sector meetings (over 250 participants in total) including 37 large companies and 71 small- and medium-sized entreprises (SME).

Presentation of a report proposing a first training plan linked to the French Plan for Genomic Medicine 2025. - September 2019